Remarkably, switch from HF-HSD to NCD in mice with NASH, completely reversed steatosis, hepatocyte ballooning, inflammation and fibrosis (Fig. 3a). This evidence concerns the gene CHST3 and metabolic dysfunction-associated steatohepatitis.